Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Chiang Mai Ram Medical Business PCL EBITDA Margin %?
Chiang Mai Ram Medical Business PCLBKK:CMR -0.79%36 EBITDA Margin % is 20.74% as of Mar. 2026, which is 9% below its 10-year median of 22.75. GuruFocus rates BKK:CMR with a GF Score™ of 36/100 and a GF Value™ of ฿0.78 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Chiang Mai Ram Medical Business PCL ranks better than 99.25% on this metric.
Chiang Mai Ram Medical Business PCL (BKK:CMR) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Chiang Mai Ram Medical Business PCL EBITDA Margin % Related Terms
Chiang Mai Ram Medical Business PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chiang Mai Ram Medical Business PCL EBITDA Margin % Chart
BKK:CMR vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Chiang Mai Ram Medical Business PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chiang Mai Ram Medical Business PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chiang Mai Ram Medical Business PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Chiang Mai Ram Medical Business PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chiang Mai Ram Medical Business PCL (BKK:CMR) has a EBITDA Margin % of 20.74% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chiang Mai Ram Medical Business PCL and its competitors. This is near median its historical median of 22.75. Over the past decade, Chiang Mai Ram Medical Business PCL's EBITDA Margin % has ranged from 18.13 to 167.68. According to the industry distribution chart, Chiang Mai Ram Medical Business PCL ranks #5 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 0.8%.
Is Chiang Mai Ram Medical Business PCL's EBITDA Margin % too high?
Chiang Mai Ram Medical Business PCL's current EBITDA Margin % of 20.74% is near median its 10-year median of 22.75. Over the past 10 years, this metric has ranged from a low of 18.13 to a high of 167.68. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Chiang Mai Ram Medical Business PCL's value of 20.74% is 102.6% above this industry median. Based on the distribution chart, Chiang Mai Ram Medical Business PCL ranks #5 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Chiang Mai Ram Medical Business PCL has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chiang Mai Ram Medical Business PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chiang Mai Ram Medical Business PCL ranks #5 out of 666 companies for EBITDA Margin %. This places Chiang Mai Ram Medical Business PCL in the top 1% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. Chiang Mai Ram Medical Business PCL's value of 20.74% is 102.6% above this benchmark. Historically, Chiang Mai Ram Medical Business PCL's own EBITDA Margin % has ranged from 18.13 to 167.68 over the past decade. While the company's 10-year median is 22.75 vs. the industry median of 10.24, Chiang Mai Ram Medical Business PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chiang Mai Ram Medical Business PCL's current EBITDA Margin % of 20.74% is 102.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chiang Mai Ram Medical Business PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chiang Mai Ram Medical Business PCL's current EBITDA Margin % is 20.74%, which is near median its own 10-year median of 22.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chiang Mai Ram Medical Business PCL stock overvalued right now?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL (BKK:CMR) is currently considered Significantly Overvalued. The stock's GF Value™ is ฿0.78, compared to a current price of ฿1.26 — trading 61.5% above its estimated fair value. The current EBITDA Margin % is 20.74%, which is near median its 10-year median of 22.75 and 102.6% above the Healthcare Providers & Services industry median of 10.24. Chiang Mai Ram Medical Business PCL's overall GF Score™ is 36/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Chiang Mai Ram Medical Business PCL (BKK:CMR), the current EBITDA Margin % is 20.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chiang Mai Ram Medical Business PCL (BKK:CMR) Overvalued in 2026?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL stock appears to be overvalued.
The current stock price of ฿1.26 is trading 61.5% above its estimated GF Value™ of ฿0.78.
GuruFocus considers Chiang Mai Ram Medical Business PCL to be Significantly Overvalued.
Key valuation signals for BKK:CMR:
EBITDA Margin %: 20.74% (near median its 10-year median of 22.75)
GF Value™: ฿0.78 vs. price of ฿1.26 (61.5% above fair value)
Industry Position: 102.6% above the Healthcare Providers & Services median (#5 of 666)
No single metric tells the full story. See the BKK:CMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chiang Mai Ram Medical Business PCL Business Description
Chiang Mai Ram Medical Business PCL is a Thailand-based company. It provides medical services in the nature of General Hospital, Hospital in Social Security, and the national health security office systems. It offers various medical services including a Dental center, X-ray mobile for a checkup, CT Multislice, Cardiac Catheterization Center, Back pain center, Gynecologic Cancer center, Physical therapy, Operating theatres, Laboratory, Ambulance Services, and Health checkup center, and others. The company provides medical services through the Lanna Hospital.
36GF Score
Get the complete analysis for BKK:CMR
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:CMR has been successfully added to your 
